Peloton Therapeutics, Inc., is a clinical-stage biotechnology company that discovers and develops novel small molecule cancer therapies targeting unexploited molecular vulnerabilities. Peloton Therapeutics’ lead programs are small molecule inhibitors targeting hypoxia inducible factor-2α (HIF-2α), a transcription factor implicated in the development and progression of kidney and other cancers.
View Top Employees from Peloton Therapeutics| Website | http://www.pelotontherapeutics.com/ |
| Revenue | $8.8 million |
| Funding | $104.3 million |
| Employees | 27 (10 on RocketReach) |
| Founded | 2011 |
| Phone | (972) 629-4100 |
| Technologies |
JavaScript,
HTML,
Twitter
+10 more
(view full list)
|
| Industry | Pharmaceuticals, Biotechnology, Oncology, Healthcare, Science and Engineering, Small molecule, Drug Manufacturing & Research, Medical Device, Drug discovery, Health Care, Drug development, Pharmaceutical, Immuno-oncology, Therapeutics |
| Web Rank | 1 Million |
| Keywords | Peloton Therapeutics, Peloton Therapeutics, Inc., Hif-2Α Inhibitor, Bicycle Therapeutics Plc, Peloton Therapeutics, |
| Competitors | Hansa Medical AB, Lengo Therapeutics, Selecta Biosciences, Tarveda Therapeutics |
| SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Peloton Therapeutics employee's phone or email?
Peloton Therapeutics Questions
The Peloton Therapeutics annual revenue was $8.8 million in 2023.
10 people are employed at Peloton Therapeutics.
Peloton Therapeutics is based in Dallas, Texas.
The NAICS codes for Peloton Therapeutics are [325, 32, 32541, 3254].
The SIC codes for Peloton Therapeutics are [283, 2834, 28].
Top Peloton Therapeutics Employees
-
5+5+
-
35+
-
ViewRosalie Drayton
Executive Assistant To Chief Executive Officer at Peloton Therapeutics
Dallas, Texas, United States -
31
-
3
-
14
-
11
Related Companies
